PMV PHARMACEUTICALS INC (PMVP)
US69353Y1038 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to PMVP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.99. This target is 491.85% above the current price.
PMVP was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about PMVP.
In the previous month the buy percentage consensus was at a similar level.
PMVP was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | Craig-Hallum | Initiate | Buy |
| 2024-04-12 | Jefferies | Initiate | Buy |
| 2024-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-27 | Ladenburg Thalmann | Initiate | Buy |
| 2023-10-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-11 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-03-20 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-02 | Oppenheimer | Maintains | Outperform |
| 2022-11-17 | HC Wainwright & Co. | Maintains | Buy |
| 2022-06-09 | Oppenheimer | Maintains | Outperform |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-03-02 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2021-09-22 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2021-08-19 | Oppenheimer | Initiate | Perform |
| 2021-08-02 | Guggenheim | Initiate | Buy |
| 2021-07-29 | HC Wainwright & Co. | Initiate | Buy |